IN 30728
Alternative Names: IN-30728Latest Information Update: 07 Sep 2023
At a glance
- Originator InxMed
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 31 Aug 2023 Early research in Solid tumours in China (InxMed pipeline, August 2023)